Metabolic syndrome in the young: Diagnosis and treatment;Síndrome metabólico en jóvenes: Diagnóstico y tratamiento

Revista Espanola de Cardiologia

Volumn 58, Issue SUPPL. 2, 2005, Pages 3-13

  Brandão, Ayrton P ^a,b   Magalhães, Marie E C ^a   Pozzan, Roberto ^a   Brandão, Andrea A ^a  

^a HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^b INSTITUTO DE PESQUISAS JARDIM BOTÂNICO DO RIO DE JANEIRO   (Brazil)

Author keywords

Adolescents; Cardiovascular mortality; Children; Metabolic syndrome

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

CALORIC RESTRICTION; CARDIOVASCULAR RISK; CHILD; CHILD CARE; CLINICAL FEATURE; CONFERENCE PAPER; EXERCISE; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LOW CARBOHYDRATE DIET; LOW FAT DIET; METABOLIC SYNDROME X; MORTALITY; OBESITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIMARY PREVENTION; RISK MANAGEMENT; RISK REDUCTION; SODIUM RESTRICTION;

EID: 34547796985     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/s0300-8932(05)74090-2     Document Type: Conference Paper

References (52)

1. Lakka HM, Laaksonen DE, Lakka TA, Niskanem LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-16.
2. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003;26:575-81.
3. Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation. 2003;108:1541-5.
4. Gang H, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, for the DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men in women. Arch Intern Med. 2004;164:1066-76.
5. Girman CJ, Rhodes T, Mercuri M, Pyörälä K, Kjekshus J, Pedersen TR, et al; for the 4S Group and the AFCAPS/TexCAPS Research Group. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol. 2004;93:136-41.
6. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final Report. Circulation. 2002;106:3143-421.
7. Kannel WB. Epidemiological contributions to preventive cardiology and challengers for the twenty-first century. En: Wong ND, Black HR, Gardin JM, editors. Preventive cardiology. New York: McGraw-Hill; 2000. p. 3-20.
8. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factors categories. Circulation. 1998;97:1837-47.
9. Berenson GS, Srinivisan SR, Bao W, Newman III WP, Tracy RE, Wattigney WA, for the Bogalusa Heart Study. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med. 1998;338:650-6.
10. Berenson G, Wattigney W, Tracy R, Bao W, Srinivisan SR, Newman III WP. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (the Bogalusa Heart Study). Am J Cardiol. 1992;70:851-8.
11. Lieberman E. Hypertension in childhood and adolescence. En: Kaplan NM, editor. Clinical Hypertension. 8th ed. Baltimore: Williams & Wilkins; 2002. p. 407-20.
12. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362:74.
13. Daniels SR, Morrison JA, Sprecher DL, Khoury P, Kimball TR. Association of body fat distribution and cardiovascular risk factors in children and adolescents. Circulation. 1999;99:541-5.
14. Brandão AA, Pozzan R, Albanesi FFM, Brandão AP. Role of anthropometric indexes and blood pressure as determinants of left ventricular mass and geometry in adolescents: the Rio de Janeiro Study. Hypertension. 1995;26:1190-4.
15. Brandão AP. A importância do desenvolvimento físico no comportamento da curva de pressão arterial em crianças de 6 a 9 anos de idade. Arq Bras Cardiol. 1987;48:203-9.
16. Henrissen EJ. Exercise effects of muscle insulin signaling and action. Invited review: effects of acute exercise and exercise training on insulin resistance. J Appl Physiol. 2002;93:788-96.
17. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes and cardiovascular risk in children. Circulation 2003;107:1448-53.
18. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome. Circulation. 2004;109:433-8.
19. PDAY Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: a preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA. 1990;264:3018-24.
20. Newman III WP, Wattigney W, Berenson G. Autopsy studies in United States children and adolescents: relationship of risk factors to atherosclerotic lesions. Ann NY Acad Sci. 1991;623:16-25.
21. Brandão AP, Brandão AA, Araujo EMM. The significance of physical development on blood pressure curve of children between 6 and 9 years of age and its relationship with familial aggregation. J Hypertens. 1989;7 Suppl 1:S37-9.
22. Sinaiko AR. Hypertension in children. N Engl J Med. 1996;335:1968-73.
23. Bartosh SM, Aronson AJ. Childhood hypertension: an update on etiology, diagnosis and treatment. Pediatr Clin North Am. 1999;46:235-52.
24. Berenson GS, Srinivasan SR, Hunter SM, Nicklas TA, Freedman DS, Shear CL, et al. Risk factors in early life as predictors of adult heart disease: The Bogalusa Heart Study. Am J Med Sci. 1989;298:141-51.
25. Task Force on Blood Pressure Control in Children. Report of the Second Task Force on Blood Pressure Control in Children. Pediatrics. 1987;79:1-25.
26. Update on Task Force Report on High Blood Pressure in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A Working Group Report from the National High Blood Pressure Education Program. Pediatrics. 1996;98:649-58.
27. Brandão AP, Brandão AA, Araujo EMM, Oliveira RC. Familial aggregation of arterial blood pressure and possible genetic influence. Hypertension. 1992;9 Suppl II:II214-7.
28. Chen W, Srinivisan SR, Elkasabany A, Berenson GS. Cardiovascular risk factors clustering features of insulin resistance syndrome (syndrome X) in a biracial (black-white) population of children, adolescents and young adults: the Bogalusa Heart Study. Am J Epidemiol. 1999;150:667-74.
29. Lauer RM, Clarke WR, Mahoney LT, Witt J. Childhood predictors for high adult blood pressure. Pediatr Clin North Am. 1993;40:23-40.
30. Falkner B, Sadowski RH. Hypertension in children and adolescents. Am J Hypertens. 1995;8:106S-10S.
31. Munger RG, Prineas RJ, Gomes-Marin A. Persistent elevation of blood pressure among children with family history of hypertension: The Minneapolis Children's Blood Pressure Study. J Hypertens. 1988;6:647-53.
32. Wattigney WA, Weber LS, Srinivisan SR, Berenson GS. The emergency of clinically abnormal levels of cardiovascular disease risk factor variables among young adults. The Bogalusa Heart Study. Prev Med. 1995;24:617-26.
33. McCarron P, Smith GD, Okasha M, McEwen J. Blood pressure in young adulthood and mortality from cardiovascular disease. Lancet. 2000;355:1430-1.
34. Miura K, Daviglus ML, Dyer AR, Liu K, Garside DB, Stamler J, et al. Relationship of blood pressure to 25-year mortality due to coronary heart disease, and all causes in young adult men. Arch Intern Med. 2001;161:1501-8.
35. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291-7.
36. The Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med. 1997;157:2413-45.
37. Bao W, Srinivisan S, Wattigney W, Berenson GS. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood: The Bogalusa Heart Study. Arch Intern Med. 1994;154:1842-7.
38. Magalhães MEC, Pozzan R, Brandão AA, Cerqueira RCO, Roussoulières ALS, Brandão AP. Early blood pressure level as a mark of familial aggregation of metabolic cardiovascular risk factors - the Rio de Janeiro Study. J Hypertens. 1998;16:1885-9.
39. Morrison JA, Sprecher DL, Barton BA, Waclawiw MA, Daniels SR. Overweight, fat patterning and cardiovascular risk factors in black and white girls. J Pediatr. 1999;135:458-64.
40. DeFronzio RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-94.
41. Pozzan R, Brandão AA, Silva SL, Brandão AP. Hyperglycemia, hyperinsulinemia, overweight, and high blood pressure in young adults: the Rio de Janeiro Study. Hypertension. 1997;30(3pt2):650-3.
42. Ross R, Freeman JA, Janssen I. Exercise alone is an effective strategy for reducing obesity and related comorbidities. Exerc Sport Sci Rev. 2000;28:165-70.
43. Carrol S, Dudfield M. What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome. Sports Med. 2004;34:371-418.
44. Gortmaker SL, Peterson K, Wiecha J, Sobol AM, Dixit S, Fox MK, et al. Reducing obesity via a school-based interdisciplinary intervention among youth. Arch Pediatr Adolesc Med. 1999;153:409-18.
45. Bacon SL, Sherwood A, Hinderliter A, Blumenthal JA. Effects of exercise, diet and weight loss on high blood pressure. Sports Med. 2004;34:307-16.
46. Consensus Panel Guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. AHA Scientific Statement: AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update. Circulation. 2002;106:388-91.
47. Monteiro CA, Mondini L, Souza ALM, Popkin BM. The nutrition transition in Brazil. Eur J Clin Nutr. 1995;49:105-13.
48. Kavey RW, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association Guidelines for primary prevention of atherosclerotic. cardiovascular disease beginning childhood. Circulation. 2003;107:1562-6.
49. Williams CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S, et al. Cardiovascular health in childhood. Circulation. 2002;106:143-60.
50. Weinstock RS, Dai H, Wadden T. Diet and exercise in the treatment of obesity. Effects of three interventions on insulin resistance. Arch Int Med. 1998;158:2477-83.
51. Davidson MD, Traum CI, Stone EJ, Wong, ND. Children and adolescents. En: Wong ND, Black HR, Gardin JM, editors. Preventive cardiology. New York: McGraw-Hill; 2000. p. 423-44.
52. Sociedade Brasileira de Cardiología. III Diretrizes brasileiras sobre dislipidemias e Diretriz de prevenção da aterosclerose do departamento de aterosclerose da SBC. Arq Bras Cardiol. 2001;77 Supl III:1-48.